Structure, function, and genetics of lipoprotein (a)

Journal of Lipid Research

Volumn 57, Issue 8, 2016, Pages 1339-1359

  Schmidt, Konrad ^a   Noureen, Asma ^a   Kronenberg, Florian ^a   Utermann, Gerd ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cardiovascular risk factor; Copy number variation; Lipoprotein metabolism; Mendelian randomization

Indexed keywords

LIPOPROTEIN A;

COPY NUMBER VARIATION; ETHNICITY; GENE FUNCTION; GENE LOCUS; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC TRAIT; GENETIC VARIATION; HERITABILITY; HUMAN; LPA GENE; MOLECULAR EVOLUTION; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; CARDIOVASCULAR DISEASE; CHEMISTRY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PHYSIOLOGY; PROTEIN DOMAIN;

ANIMALS; CARDIOVASCULAR DISEASES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPOPROTEIN(A); POLYMORPHISM, GENETIC; PROTEIN DOMAINS;

EID: 84982764410     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R067314     Document Type: Review

References (241)

1. Berg, K. 1963. A new serum type system in man-The Lp system. Acta Pathol. Microbiol. Scand. 59: 369-382.
2. Kronenberg, F., and G. Utermann. 2013. Lipoprotein(a): resurrected by genetics. J. Intern. Med. 273: 6-30.
3. Ehnholm, C., H. Garoff, O. Renkonen, and K. Simons. 1972. Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma. Biochemistry. 11: 3229-3232.
4. Gaubatz, J. W., C. Heideman, A. M. Gotto, Jr., J. D. Morrisett, and G. H. Dahlen. 1983. Human plasma lipoprotein(a): structural properties. J. Biol. Chem. 258: 4582-4589.
5. Utermann, G., and W. Weber. 1983. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett. 154: 357-361.
6. Utermann, G. 1989. The mysteries of lipoprotein(a). Science. 246: 904-910.
7. Eaton, D. L., G. M. Fless, W. J. Kohr, J. W. McLean, Q-T. Xu, C. G. Miller, R. M. Lawn, and A. M. Scanu. 1987. Partial amino acid sequence of apolipoprotein[a] shows that it is homologous to plasminogen. Proc. Natl. Acad. Sci. USA. 84: 3224-3228.
8. Kratzin, H., V. W. Armstrong, M. Niehaus, N. Hilschmann, and D. Seidel. 1987. Structural relationship of an apolipoprotein(a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol. Chem. Hoppe Seyler. 368: 1533-1544.
9. Patthy, L. 1985. Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules. Cell. 41: 657-663.
10. Walz, D. A., D. Hewett-Emmett, and W. H. Seegers. 1977. Amino acid sequence of human prothrombin fragments 1 and 2. Proc. Natl. Acad. Sci. USA. 74: 1969-1972.
11. Gönzler, W. A., G. J. Steffens, F. Otting, S. M. Kim, E. Frankus, and L. Flohé. 1982. The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain. Hoppe Seylers Z. Physiol. Chem. 363: 1155-1165.
12. Pennica, D., W. E. Holmes, W. J. Kohr, R. N. Harkins, G. A. Vehar, C. A. Ward, W. F. Bennett, E. Yelverton, P. H. Seeburg, H. L. Heyneker, et al. 1983. Cloning and expression of human tissuetype plasminogen activator cDNA in E. coli. Nature. 301: 214-221.
13. Kraft, H. G., H. J. Menzel, F. Hoppichler, W. Vogel, and G. Utermann. 1989. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J. Clin. Invest. 83: 137-142.
14. Sommer, A., R. Gorges, G. M. Kostner, F. Paltauf, and A. Hermetter. 1991. Sulfhydryl-selective fluorescence labeling of lipoprotein(a) reveals evidence for one single disulfide linkage between apoproteins(a) and B-100. Biochemistry. 30: 11245-11249.
15. Guevara, J., Jr., J. Spurlino, A. Y. Jan, C. Yang, A. Tulinsky, B. V. Venkataram Prasad, J. W. Gaubatz, and J. D. Morrisett. 1993. Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein. [a] Biophys. J. 64: 686-700.
16. Brunner, C., H. G. Kraft, G. Utermann, and H. J. Möller. 1993. Cys(4057) of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc. Natl. Acad. Sci. USA. 90: 11643-11647.
17. White, A. L., and R. E. Lanford. 1994. Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes. J. Biol. Chem. 269: 28716-28723.
18. Dieplinger, H., and G. Utermann. 1999. The seventh myth of lipoprotein(a): where and how is it assembled? Curr. Opin. Lipidol. 10: 275-283.
19. Koschinsky, M. L., and S. M. Marcovina. 2004. Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity. Curr. Opin. Lipidol. 15: 167-174.
20. Berg, K., and J. Mohr. 1963. Genetics of the LP system. Acta Genet. Stat. Med. 13: 349-360.
21. Ehnholm, C., H. Garoff, K. Simons, and H. Aro. 1971. Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen. Biochim. Biophys. Acta. 236: 431-439.
22. Albers, J. J., and W. R. Hazzard. 1974. Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids. 9: 15-26.
23. Schultz, J. S., D. C. Schreffler, C. F. Sing, and N. R. Harvie. 1974. The genetics of the Lp antigen. I. Its quantitation and distribution in a sample population. Ann. Hum. Genet. 38: 39-46.
24. Schmidt, K., H. G. Kraft, W. Parson, and G. Utermann. 2006. Genetics of the Lp(a)/apo(a) system in an autochthonous Black African population from the Gabon. Eur. J. Hum. Genet. 14: 190-201.
25. Kraft, H. G., S. Köchl, H. J. Menzel, C. Sandholzer, and G. Utermann. 1992. The apolipoprotein(a) gene: A transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum. Genet. 90: 220-230.
26. Boerwinkle, E., C. C. Leffert, J. Lin, C. Lackner, G. Chiesa, and H. H. Hobbs. 1992. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90: 52-60.
27. Austin, M. A., C. Sandholzer, J. V. Selby, B. Newman, R. M. Krauss, and G. Utermann. 1992. Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. Am. J. Hum. Genet. 51: 829-840.
28. Rao, F., A. J. Schork, A. X. Maihofer, C. M. Nievergelt, S. M. Marcovina, E. R. Miller, J. L. Witztum, D. T. O'Connor, and S. Tsimikas. 2015. Heritability of biomarkers of oxidized lipoproteins: Twin pair study. Arterioscler. Thromb. Vasc. Biol. 35: 1704-1711.
29. Frank, S. L., I. Klisak, R. S. Sparkes, T. Mohandas, J. E. Tomlinson, J. W. McLean, R. M. Lawn, and A. J. Lusis. 1988. The apolipoprotein (a) gene resides on human chromosome 6q26-27 in close proximity to the homologous gene for plasminogen. Hum. Genet. 79: 352-356.
30. Drayna, D. T., R. A. Hegele, P. E. Hass, M. Emi, L. L. Wu, D. L. Eaton, R. M. Lawn, R. R. Williams, R. L. White, and J. M. Lalouel. 1988. Genetic linkage between lipoprotein(a) phenotype and a DNA polymorphism in the plasminogen gene. Genomics. 3: 230-236.
31. Lindahl, G., E. Gersdorf, H. J. Menzel, C. Duba, H. Cleve, S. Humphries, and G. Utermann. 1989. The gene for the Lp(a)-specific glycoprotein is closely linked to the gene for plasminogen on chromosome 6. Hum. Genet. 81: 149-152.
32. Scholz, M., H. G. Kraft, A. Lingenhel, R. Delport, E. H. Vorster, H. Bickeböller, and G. Utermann. 1999. Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians. Eur. J. Hum. Genet. 7: 169-178.
33. DeMeester, C. A., X. Bu, R. J. Gray, A. J. Lusis, and J. I. Rotter. 1995. Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. Am. J. Hum. Genet. 56: 287-293.
34. Mooser, V., D. Scheer, S. M. Marcovina, J. P. Wang, R. Guerra, J. Cohen, and H. H. Hobbs. 1997. The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans. Am. J. Hum. Genet. 61: 402-417.
35. Sandholzer, C., D. M. Hallman, N. Saha, G. Sigurdsson, C. Lackner, A. Császár, E. Boerwinkle, and G. Utermann. 1991. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum. Genet. 86: 607-614.
36. Kraft, H. G., A. Lingenhel, R. W. C. Pang, R. Delport, M. Trommsdorff, H. Vermaak, E. D. Janus, and G. Utermann. 1996. Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: The distribution of null alleles is nonrandom. Eur. J. Hum. Genet. 4: 74-87.
37. Gaw, A., E. Boerwinkle, J. C. Cohen, and H. H. Hobbs. 1994. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups: evidence for no common "null" allele at the apo(a) locus. J. Clin. Invest. 93: 2526-2534.
38. Williams-Blangero, S., and D. L. Rainwater. 1991. Variation in Lp(a) levels and apo(a) isoform frequencies in five baboon subspecies. Hum. Biol. 63: 65-76.
39. Doucet, C., T. Huby, J. Chapman, and J. Thillet. 1994. Lipoprotein[a] in the chimpanzee: relationship of apo[a] phenotype to elevated plasma Lp[a] levels. J. Lipid Res. 35: 263-270.
40. Lawn, R. M., K. Schwartz, and L. Patthy. 1997. Convergent evolution of apolipoprotein(a) in primates and hedgehog. Proc. Natl. Acad. Sci. USA. 94: 11992-11997.
41. McLean, J. W., J. E. Tomlinson, W-J. Kuang, D. L. Eaton, E. Y. Chen, G. M. Fless, A. M. Scanu, and R. M. Lawn. 1987. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 330: 132-137.
42. Tomlinson, J. E., J. W. McLean, and R. M. Lawn. 1989. Rhesus monkey apolipoprotein(a). Sequence, evolution, and sites of synthesis. J. Biol. Chem. 264: 5957-5965.
43. Leibundgut, G., C. Scipione, H. Yin, M. Schneider, M. B. Boffa, S. Green, X. Yang, E. Dennis, J. L. Witztum, M. L. Koschinsky, et al. 2013. Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a). J. Lipid Res. 54: 2815-2830.
44. Haibach, C., H. G. Kraft, S. Köchl, A. Abe, and G. Utermann. 1998. The number of kringle IV repeats 3-10 is invariable in the human apo(a) gene. Gene. 208: 253-258.
45. Utermann, G., H. J. Menzel, H. G. Kraft, H. C. Duba, H. G. Kemmler, and C. Seitz. 1987. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J. Clin. Invest. 80: 458-465.
46. Byrne, C. D., K. Schwartz, K. Meer, J. F. Cheng, and R. M. Lawn. 1994. The human apolipoprotein(a)/plasminogen gene cluster contains a novel homologue transcribed in liver. Arterioscler. Thromb. 14: 534-541.
47. Kraft, H. G., C. Sandholzer, H. J. Menzel, and G. Utermann. 1992. Apolipoprotein(a) alleles determine lipoprotein(a) particle density and concentration in plasma. Arterioscler. Thromb. 12: 302-306.
48. Koschinsky, M. L., G. P. Côté, B. Gabel, and Y. Y. Van der Hoek. 1993. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J. Biol. Chem. 268: 19819-19825.
49. McCormick, S. P. A., J. K. No, S. Taylor, L. M. Flynn, R. E. Hammer, and S. G. Young. 1995. Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a). Proc. Natl. Acad. Sci. USA. 92: 10147-10151.
50. Callow, M. J., and E. M. Rubin. 1995. Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein(a) in vivo. J. Biol. Chem. 270: 23914-23917.
51. Xu, S. 1998. Apolipoprotein(a) binds to low-density lipoprotein at two distant sites in lipoprotein(a). Biochemistry. 37: 9284-9294.
52. Phillips, M. L., A. V. Lembertas, V. N. Schumaker, R. M. Lawn, S. J. Shire, and T. F. Zioncheck. 1993. Physical properties of recombinant apolipoprotein(a) and its association with LDL to form an Lp(a)-like complex. Biochemistry. 32: 3722-3728.
53. Ogorelkova, M., A. Gruber, and G. Utermann. 1999. Molecular basis of congenital Lp(a) deficiency: A frequent apo(a) 'null' mutation in Caucasians. Hum. Mol. Genet. 8: 2087-2096.
54. Lim, E. T., P. Wurtz, A. S. Havulinna, P. Palta, T. Tukiainen, K. Rehnstrom, T. Esko, R. Magi, M. Inouye, T. Lappalainen, et al. 2014. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet. 10: e1004494.
55. Miles, L. A., and E. F. Plow. 1990. Lp(a): An interloper into the fibrinolytic system. Thromb. Haemost. 63: 331-335.
56. Koschinsky, M. L. 2006. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers? Cardiovasc. Hematol. Disord. Drug Targets. 6: 267-278.
57. Boffa, M. B., and M. L. Koschinsky. 2015. Lipoprotein(a): Truly a direct prothrombotic factor in cardiovascular disease? J. Lipid Res. In press.
58. Kamstrup, P. R., A. Tybjaerg-Hansen, and B. G. Nordestgaard. 2012. Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis. Arterioscler. Thromb. Vasc. Biol. 32: 1732-1741.
59. Helgadottir, A., S. Gretarsdottir, G. Thorleifsson, H. Holm, R. S. Patel, T. Gudnason, G. T. Jones, A. M. van Rij, D. J. Eapen, A. F. Baas, et al. 2012. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J. Am. Coll. Cardiol. 60: 722-729.
60. Brown, M. S., and J. L. Goldstein. 1987. Plasma lipoproteins: Teaching old dogmas new tricks. Nature. 330: 113-114.
61. Pillarisetti, S., L. Paka, J. C. Obunike, L. Berglund, and I. J. Goldberg. 1997. Subendothelial retention of lipoprotein (a)-Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. J. Clin. Invest. 100: 867-874.
62. Hughes, S. D., X. J. Lou, S. Ighani, J. Verstuyft, D. J. Grainger, R. M. Lawn, and E. M. Rubin. 1997. Lipoprotein(a) vascular accumulation in mice-in vivo analysis of the role of lysine binding sites using recombinant adenovirus. J. Clin. Invest. 100: 1493-1500.
63. Keesler, G. A., B. R. Gabel, C. M. Devlin, M. L. Koschinsky, and I. Tabas. 1996. The binding activity of the macrophage lipoprotein(a) apolipoprotein(a) receptor is induced by cholesterol via a post-Translational mechanism and recognizes distinct kringle domains on apolipoprotein(a). J. Biol. Chem. 271: 32096-32104.
64. Higazi, A. A. R., E. Lavi, K. Bdeir, A. M. Ulrich, D. G. Jamieson, D. J. Rader, D. C. Usher, W. Kane, T. Ganz, and D. B. Cines. 1997. Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells. Blood. 89: 4290-4298.
65. Kostner, G. M., and M. Bihari-Varga. 1990. Is the atherogenicity of Lp(a) caused by its reactivity with proteoglycans? Eur. Heart J. 11: 184-189.
66. van der Hoek, Y. Y., W. Sangrar, G. P. Côté, J. J. P. Kastelein, and M. L. Koschinsky. 1994. Binding of recombinant apolipoprotein(a) to extracellular matrix proteins. Arterioscler. Thromb. 14: 1792-1798.
67. Kapetanopoulos, A., F. Fresser, G. Millonig, Y. Shaul, G. Baier, and G. Utermann. 2002. Direct interaction of the extracellular matrix protein DANCE with apolipoprotein(a) mediated by the kringle IV-Type 2 domain. Mol. Genet. Genomics. 267: 440-446.
68. Walton, K. W., J. Hitchens, H. N. Magnani, and M. Khan. 1974. A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis. Atherosclerosis. 20: 323-346.
69. Donate, L. E., E. Gherardi, N. Srinivasan, R. Sowdhamini, S. Aparicio, and T. L. Blundell. 1994. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci. 3: 2378-2394.
70. Wade, D. P., J. G. Clarke, G. E. Lindahl, A. C. Liu, B. R. Zysow, K. Meer, K. Schwartz, and R. M. Lawn. 1993. 5′ control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc. Natl. Acad. Sci. USA. 90: 1369-1373.
71. Noma, A., A. Abe, S. Maeda, M. Seishima, K. Makino, Y. Yano, and K. Shimokawa. 1994. Lp(a): An acute-phase reactant. Chem. Phys. Lipids. 67-68: 411-417.
72. Lippi, G., V. Braga, S. Adami, and G. Guidi. 1998. Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. Clin. Chim. Acta. 271: 79-87.
73. Chimienti, G., F. Aquilino, M. T. Rotelli, F. Russo, L. Lupo, and G. Pepe. 2006. Lipoprotein(a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery. Br. J. Surg. 93: 347-353.
74. Mooser, V., M. M. Berger, L. Tappy, C. Cayeux, S. M. Marcovina, R. Darioli, P. Nicod, and R. Chiolero. 2000. Major reduction in plasma Lp(a) levels during sepsis and burns. Arterioscler. Thromb. Vasc. Biol. 20: 1137-1142.
75. Ramharack, R., D. Barkalow, and M. A. Spahr. 1998. Dominant negative effect of TGF-b1 and TNF-A on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler. Thromb. Vasc. Biol. 18: 984-990.
76. Möller, N., D. M. Schulte, K. Törk, S. Freitag-Wolf, J. Hampe, R. Zeuner, J. O. Schröder, I. Gouni-Berthold, H. K. Berthold, W. Krone, et al. 2015. IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans. J. Lipid Res. 56: 1034-1042.
77. Bergmark, C., A. Dewan, A. Orsoni, E. Merki, E. R. Miller, M. J. Shin, C. J. Binder, S. Horkko, R. M. Krauss, M. J. Chapman, et al. 2008. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J. Lipid Res. 49: 2230-2239.
78. Tsimikas, S., E. S. Brilakis, E. R. Miller, J. P. McConnell, R. J. Lennon, K. S. Kornman, J. L. Witztum, and P. B. Berger. 2005. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N. Engl. J. Med. 353: 46-57.
79. Kiechl, S., J. Willeit, M. Mayr, B. Viehweider, F. Oberhollenzer, F. Kronenberg, C. J. Wiedermann, S. Oberthaler, Q. Xu, J. L. Witztum, et al. 2007. Oxidized phospholipids, lipoprotein(a), lipoprotein-Associated phospholipase A2 activity and 10-year cardiovascular outcomes: prospective results from the Bruneck study. Arterioscler. Thromb. Vasc. Biol. 27: 1788-1795.
80. Salonen, E. M., M. Jauhiainen, L. Zardi, A. Vaheri, and C. Ehnholm. 1989. Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it. EMBO J. 8: 4035-4040.
81. Jauhiainen, M., J. Metso, P. Koskinen, and C. Ehnholm. 1991. Characterization of the enzyme activity of human plasma lipoprotein (a) using synthetic peptide substrates. Biochem. J. 274: 491-496.
82. Mora, S., P. R. Kamstrup, N. Rifai, B. G. Nordestgaard, J. E. Buring, and P. M. Ridker. 2010. Lipoprotein(a) and risk of type 2 diabetes. Clin. Chem. 56: 1252-1260.
83. Kamstrup, P. R., and B. G. Nordestgaard. 2013. Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: A Mendelian randomisation study. Lancet Diabetes Endocrinol. 1: 220-227.
84. Ye, Z., P. C. Haycock, D. Gurdasani, C. Pomilla, S. M. Boekholdt, S. Tsimikas, K. T. Khaw, N. J. Wareham, M. S. Sandhu, and N. G. Forouhi. 2014. The association between circulating lipoprotein(a) and type 2 diabetes: is it causal? Diabetes. 63: 332-342.
85. Ding, L., A. Song, M. Dai, M. Xu, W. Sun, B. Xu, J. Sun, T. Wang, Y. Xu, J. Lu, et al. 2015. Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-Aged and elderly Chinese population. J. Lipid Res. 56: 920-926.
86. Azrolan, N., D. Gavish, and J. L. Breslow. 1991. Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. J. Biol. Chem. 266: 13866-13872.
87. Koschinsky, M. L., U. Beisiegel, D. Henne-Bruns, D. L. Eaton, and R. M. Lawn. 1990. Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry. 29: 640-644.
88. Brunner, C., E. M. Lobentanz, A. Pethö-Schramm, A. Ernst, C. Kang, H. Dieplinger, H. J. Möller, and G. Utermann. 1996. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells. J. Biol. Chem. 271: 32403-32410.
89. Su, W., H. Campos, H. Judge, B. W. Walsh, and F. M. Sacks. 1998. Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement. J. Clin. Endocrinol. Metab. 83: 3267-3276.
90. Krempler, F., G. M. Kostner, A. Roscher, F. Haslauer, K. Bolzano, and F. Sandhofer. 1983. Studies on the role of specific cell surface receptors in the removal of lipoprotein(a) in man. J. Clin. Invest. 71: 1431-1441.
91. Hofer, G., E. Steyrer, G. M. Kostner, and A. Hermetter. 1997. LDL-mediated interaction of Lp[a] with HepG2 cells: A novel fluorescence microscopy approach. J. Lipid Res. 38: 2411-2421.
92. Niemeier, A., T. Willnow, H. Dieplinger, C. Jacobsen, N. Meyer, J. Hilpert, and U. Beisiegel. 1999. Identification of Megalin/gp330 as a receptor for lipoprotein(a) in vitro. Arterioscler. Thromb. Vasc. Biol. 19: 552-561.
93. Krempler, F., G. M. Kostner, K. Bolzano, and F. Sandhofer. 1980. Turnover of lipoprotein(a) in man. J. Clin. Invest. 65: 1483-1490.
94. Perombelon, Y. F. N., A. K. Soutar, and B. L. Knight. 1994. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J. Clin. Invest. 93: 1481-1492.
95. Rader, D. J., W. Cain, K. Ikewaki, G. Talley, L. A. Zech, D. Usher, and H. B. Brewer. 1994. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J. Clin. Invest. 93: 2758-2763.
96. Cain, W. J., J. S. Millar, A. S. Himebauch, U. J. Tietge, C. Maugeais, D. Usher, and D. J. Rader. 2005. Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]. J. Lipid Res. 46: 2681-2691.
97. Seed, M., F. Hoppichler, D. Reaveley, S. McCarthy, G. R. Thompson, E. Boerwinkle, and G. Utermann. 1990. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N. Engl. J. Med. 322: 1494-1499.
98. Kraft, H. G., A. Lingenhel, F. J. Raal, M. Hohenegger, and G. Utermann. 2000. Lipoprotein(a) in homozygous familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 20: 522-528.
99. Utermann, G., F. Hoppichler, H. Dieplinger, M. Seed, G. Thompson, and E. Boerwinkle. 1989. Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc. Natl. Acad. Sci. USA. 86: 4171-4174.
100. Wiklund, O., B. Angelin, S-O. Olofsson, M. Eriksson, G. Fager, L. Berglund, and G. Bondjers. 1990. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet. 335: 1360-1363.
101. Mbewu, A. D., D. Bhatnagar, P. N. Durrington, L. Hunt, M. Ishola, S. Arrol, M. Mackness, P. Lockley, and J. P. Miller. 1991. Serum lipoprotein(a) in patients heterozygous familial hypercholesterolaemia, their relatives, and unrelated control populations. Arterioscler. Thromb. 11: 940-946.
102. Friedlander, Y., and E. Leitersdorf. 1995. Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia. Genet. Epidemiol. 12: 129-143.
103. Tada, H., M. A. Kawashiri, T. Yoshida, R. Teramoto, A. Nohara, T. Konno, A. Inazu, H. Mabuchi, M. Yamagishi, and K. Hayashi. 2016. Lipoprotein(a) in familial hypercholesterolemia with proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutations. Circ. J. 80: 512-518.
104. Soutar, A. K., S. N. McCarthy, M. Seed, and B. L. Knight. 1991. Relationship between apolipoprotein (a) phenotype, lipoprotein (a) concentration in plasma, and low density lipoprotein (LDL) receptor function in a large kindred with familial hypercholesterolemia due to the Pro664-Leu mutation in the LDL-receptor gene. J. Clin. Invest. 88: 483-492.
105. Ghiselli, G., A. Gaddi, G. Barozzi, A. Ciarrocchi, and G. Descovich. 1992. Plasma lipoprotein(a) concentration in familial hypercholesterolemic patients without coronary artery disease. Metabolism. 41: 833-838.
106. Jansen, A. C., E. S. van Aalst-Cohen, M. W. Tanck, M. D. Trip, P. J. Lansberg, A. H. Liem, H. W. van Lennep, E. J. Sijbrands, and J. J. Kastelein. 2004. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J. Intern. Med. 256: 482-490.
107. Miller, P. E., S. S. Martin, P. P. Toth, R. D. Santos, M. J. Blaha, K. Nasir, S. S. Virani, W. S. Post, R. S. Blumenthal, and S. R. Jones. 2015. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids study-17 (VLDL-17). J. Clin. Lipidol. 9: 676-683.
108. Leitersdorf, E., Y. Friedlander, J-M. Bard, J-C. Fruchart, S. Eisenberg, and Y. Stein. 1991. Diverse effect of ethnicity on plasma lipoprotein[a] levels in heterozygote patients with familial hypercholesterolemia. J. Lipid Res. 32: 1513-1519.
109. Raal, F. J., R. P. Giugliano, M. S. Sabatine, M. J. Koren, G. Langslet, H. Bays, D. Blom, M. Eriksson, R. Dent, S. M. Wasserman, et al. 2014. Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): A pooled analysis of more than 1, 300 patients in 4 phase II trials. J. Am. Coll. Cardiol. 63: 1278-1288.
110. Kostner, G. M., D. Gavish, B. Leopold, K. Bolzano, M. S. Weintraub, and J. L. Breslow. 1989. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation. 80: 1313-1319.
111. Khera, A. V., B. M. Everett, M. P. Caulfield, F. M. Hantash, J. Wohlgemuth, P. M. Ridker, and S. Mora. 2014. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: An analysis from the JUPITER trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin). Circulation. 129: 635-642.
112. Kronenberg, F. 2014. Lipoprotein(a): There's life in the old dog yet. Circulation. 129: 619-621.
113. Kronenberg, F., G. Utermann, and H. Dieplinger. 1996. Lipoprotein(a) in renal disease. Am. J. Kidney Dis. 27: 1-25.
114. Kronenberg, F. 2014. Causes and consequences of lipoprotein(a) abnormalities in kidney disease. Clin. Exp. Nephrol. 18: 234-237.
115. Kostner, K. M., G. Maurer, K. Huber, T. Stefenelli, H. Dieplinger, E. Steyrer, and G. M. Kostner. 1996. Urinary excretion of apo(a) fragments. Role in apo(a) catabolism. Arterioscler. Thromb. Vasc. Biol. 16: 905-911.
116. Mooser, V., S. M. Marcovina, A. L. White, and H. H. Hobbs. 1996. Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine. J. Clin. Invest. 98: 2414-2424.
117. Kronenberg, F., E. Trenkwalder, A. Lingenhel, G. Friedrich, K. Lhotta, M. Schober, N. Moes, P. König, G. Utermann, and H. Dieplinger. 1997. Renovascular arteriovenous differences in Lp(a) plasma concentrations suggest removal of Lp(a) from the renal circulation. J. Lipid Res. 38: 1755-1763.
118. Hixson, J. E., M. L. Britten, G. S. Manis, and D. L. Rainwater. 1989. Apolipoprotein(a) (Apo(a)) glycoprotein isoforms result from size differences in Apo(a) mRNA in baboons. J. Biol. Chem. 264: 6013-6016.
119. Rainwater, D. L., and G. S. Manis. 1988. Immunochemical characterization and quantitation of lipoprotein(a) in baboons. Development of an assay depending on two antigenetically distinct proteins. Atherosclerosis. 73: 23-31.
120. Laplaud, P. M., L. Beaubatie, S. C. Rall, Jr., G. Luc, and M. Saboureau. 1988. Lipoprotein[a] is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus). J. Lipid Res. 29: 1157-1170.
121. Lawn, R. M., N. W. Boonmark, K. Schwartz, G. E. Lindahl, D. P. Wade, C. D. Byrne, K. J. Fong, K. Meer, and L. Patthy. 1995. The recurring evolution of lipoprotein(a). Insights from cloning of hedgehog apolipoprotein(a). J. Biol. Chem. 270: 24004-24009.
122. Guo, H. C., J. B. Michel, Y. Blouquit, and M. J. Chapman. 1991. Lipoprotein(a) and apolipoprotein(a) in a New World monkey, the common marmoset (Callithrix jacchus). Association of variable plasma lipoprotein(a) levels with a single apolipoprotein(a) isoform. Arterioscler. Thromb. 11: 1030-1041.
123. Rath, M., and L. Pauling. 1990. Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. Proc. Natl. Acad. Sci. USA. 87: 9388-9390.
124. Chen, T. J., C. Y. Ji, and Y. H. Hu. 2009. Genetic and environmental influences on serum lipids and the effects of puberty: A Chinese twin study. Acta Paediatr. 98: 1029-1036.
125. Ober, C., M. Abney, and M. S. McPeek. 2001. The genetic dissection of complex traits in a founder population. Am. J. Hum. Genet. 69: 1068-1079.
126. Rao, V. S., N. B. Khadrinarasimhaih, S. Kanjilal, M. Mukerjee, and V. V. Kakkar. 2009. Genetic contribution to variation in atherothrombotic phenotypes in the Asian Indian population. The Indian Atherosclerosis Research Study. Thromb. Haemost. 102: 379-388.
127. Hong, Y., G. H. Dahlén, N. Pedersen, D. A. Heller, G. E. McClearn, and U. de Faire. 1995. Potential environmental effects on adult lipoprotein(a) levels: Results from Swedish twins. Atherosclerosis. 117: 295-304.
128. Ober, C., A. S. Nord, E. E. Thompson, L. Pan, Z. Tan, D. Cusanovich, Y. Sun, R. Nicolae, C. Edelstein, D. H. Schneider, et al. 2009. Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q. J. Lipid Res. 50: 798-806.
129. Broeckel, U., C. Hengstenberg, B. Mayer, S. Holmer, L. J. Martin, A. G. Comuzzie, J. Blangero, P. Nurnberg, A. Reis, G. A. Riegger, et al. 2002. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30: 210-214.
130. Barlera, S., C. Specchia, M. Farrall, B. D. Chiodini, M. G. Franzosi, S. Rust, F. Green, E. B. Nicolis, J. Peden, G. Assmann, et al. 2007. Multiple QTL influence the serum Lp(a) concentration: A genome-wide linkage screen in the PROCARDIS study. Eur. J. Hum. Genet. 15: 221-227.
131. Feuk, L., A. R. Carson, and S. W. Scherer. 2006. Structural variation in the human genome. Nat. Rev. Genet. 7: 85-97.
132. Parson, W., H. G. Kraft, H. Niederstatter, A. W. Lingenhel, S. Kochl, F. Fresser, and G. Utermann. 2004. A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a). Hum. Mutat. 24: 474-480.
133. Røsby, O., P. Aleström, and K. Berg. 2000. Sequence conservation in kringle IV-Type 2 repeats of the LPA gene. Atherosclerosis. 148: 353-364.
134. Rösby, O., P. Aleström, and K. Berg. 1997. High-degree sequence conservation in LPA kringle IV-Type 2 exons and introns. Clin. Genet. 52: 293-302.
135. Chen, J. M., D. N. Cooper, N. Chuzhanova, C. Ferec, and G. P. Patrinos. 2007. Gene conversion: mechanisms, evolution and human disease. Nat. Rev. Genet. 8: 762-775.
136. Enkhmaa, B., E. Anuurad, and L. Berglund. 2015. Lipoprotein(a): impact by ethnicity, environmental and medical conditions. J. Lipid Res. In press.
137. Lackner, C., E. Boerwinkle, C. C. Leffert, T. Rahmig, and H. H. Hobbs. 1991. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J. Clin. Invest. 87: 2153-2161.
138. Kamstrup, P. R., A. Tybjaerg-Hansen, R. Steffensen, and B. G. Nordestgaard. 2009. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 301: 2331-2339.
139. Erdel, M., M. Hubalek, A. Lingenhel, K. Kofler, H. C. Duba, and G. Utermann. 1999. Counting the repetitive kringle-IV repeats in the gene encoding human apolipoprotein(a) by fibre-FISH. Nat. Genet. 21: 357-358.
140. Stankiewicz, P., C. J. Shaw, M. Withers, K. Inoue, and J. R. Lupski. 2004. Serial segmental duplications during primate evolution result in complex human genome architecture. Genome Res. 14: 2209-2220.
141. Nahon, J. L. 2003. Birth of 'human-specific' genes during primate evolution. Genetica. 118: 193-208.
142. Bailey, J. A., and E. E. Eichler. 2006. Primate segmental duplications: crucibles of evolution, diversity and disease. Nat. Rev. Genet. 7: 552-564.
143. Dumas, L., Y. H. Kim, A. Karimpour-Fard, M. Cox, J. Hopkins, J. R. Pollack, and J. M. Sikela. 2007. Gene copy number variation spanning 60 million years of human and primate evolution. Genome Res. 17: 1266-1277.
144. Inoue, K., M. Khajavi, T. Ohyama, S. Hirabayashi, J. Wilson, J. D. Reggin, P. Mancias, I. J. Butler, M. F. Wilkinson, M. Wegner, et al. 2004. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat. Genet. 36: 361-369.
145. Gonzalez, E., H. Kulkarni, H. Bolivar, A. Mangano, R. Sanchez, G. Catano, R. J. Nibbs, B. I. Freedman, M. P. Quinones, M. J. Bamshad, et al. 2005. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science. 307: 1434-1440.
146. Perry, G. H., N. J. Dominy, K. G. Claw, A. S. Lee, H. Fiegler, R. Redon, J. Werner, F. A. Villanea, J. L. Mountain, R. Misra, et al. 2007. Diet and the evolution of human amylase gene copy number variation. Nat. Genet. 39: 1256-1260.
147. Stankiewicz, P., and J. R. Lupski. 2010. Structural variation in the human genome and its role in disease. Annu. Rev. Med. 61: 437-455.
148. Castellino, F. J., V. A. Ploplis, J. R. Powell, and D. K. Strickland. 1981. The existence of independent domain structures in human Lys77-plasminogen. J. Biol. Chem. 256: 4778-4782.
149. Ploplis, V. A., D. K. Strickland, and F. J. Castellino. 1981. Calorimetric evaluation of the existence of separate domains in bovine prothrombin. Biochemistry. 20: 15-21.
150. Esmon, C. T., and C. M. Jackson. 1974. The conversion of prothrombin to thrombin. IV. The function of the fragment 2 region during activation in the presence of factor V. J. Biol. Chem. 249: 7791-7797.
151. Lerch, P. G., E. E. Rickli, W. Lergier, and D. Gillessen. 1980. Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties. Eur. J. Biochem. 107: 7-13.
152. Váradi, A., and L. Patthy. 1981. Kringle 5 of human plasminogen carries a benzamidine-binding site. Biochem. Biophys. Res. Commun. 103: 97-102.
153. Patthy, L., M. Trexler, Z. Vali, L. Banyai, and A. Varadi. 1984. Kringles: modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases. FEBS Lett. 171: 131-136.
154. Köchl, S., F. Fresser, E. Lobentanz, G. Baier, and G. Utermann. 1997. Novel interaction of apolipoprotein(a) with beta-2 glycoprotein I mediated by the kringle IV domain. Blood. 90: 1482-1489.
155. Enkhmaa, B., A. Abbuthalha, E. Anuurad, W. Zhang, A. F. Tarantal, and L. Berglund. 2015. Rhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms. J. Med. Primatol. 44: 117-124.
156. Puckey, L. H., R. M. Lawn, and B. L. Knight. 1997. Polymorphisms in the apolipoprotein(a) gene and their relationship to allele size and plasma lipoprotein(a) concentration. Hum. Mol. Genet. 6: 1099-1107.
157. Clarke, R., J. F. Peden, J. C. Hopewell, T. Kyriakou, A. Goel, S. C. Heath, S. Parish, S. Barlera, M. G. Franzosi, S. Rust, et al. 2009. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N. Engl. J. Med. 361: 2518-2528.
158. Lackner, C., J. C. Cohen, and H. H. Hobbs. 1993. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum. Mol. Genet. 2: 933-940.
159. Kamstrup, P. R., M. Benn, A. Tybaerg-Hansen, and B. G. Nordestgaard. 2008. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: The Copenhagen City Heart Study. Circulation. 117: 176-184.
160. Berglund, L., and E. Anuurad. 2008. Role of lipoprotein(a) in cardiovascular disease current and future perspectives. J. Am. Coll. Cardiol. 52: 132-134.
161. Bennet, A., A. E. Di, S. Erqou, G. Eiriksdottir, G. Sigurdsson, M. Woodward, A. Rumley, G. D. Lowe, J. Danesh, and V. Gudnason. 2008. Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch. Intern. Med. 168: 598-608.
162. Danesh, J., R. Collins, and R. Peto. 2000. Lipoprotein(a) and coronary heart disease: meta-Analysis of prospective studies. Circulation. 102: 1082-1085.
163. Sandholzer, C., N. Saha, J. D. Kark, A. Rees, W. Jaross, H. Dieplinger, F. Hoppichler, E. Boerwinkle, and G. Utermann. 1992. Apo(a) isoforms predict risk for coronary heart disease: A study in six populations. Arterioscler. Thromb. 12: 1214-1226.
164. Erqou, S., A. Thompson, A. E. Di, D. Saleheen, S. Kaptoge, S. Marcovina, and J. Danesh. 2010. Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58, 000 participants. J. Am. Coll. Cardiol. 55: 2160-2167.
165. Kraft, H. G., A. Lingenhel, S. Köchl, F. Hoppichler, F. Kronenberg, A. Abe, V. Möhlberger, D. Schönitzer, and G. Utermann. 1996. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 16: 713-719.
166. Wild, S. H., S. P. Fortmann, and S. M. Marcovina. 1997. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler. Thromb. Vasc. Biol. 17: 239-245.
167. Kronenberg, F., M. F. Kronenberg, S. Kiechl, E. Trenkwalder, P. Santer, F. Oberhollenzer, G. Egger, G. Utermann, and J. Willeit. 1999. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation. 100: 1154-1160.
168. White, A. L., B. Guerra, and R. E. Lanford. 1997. Influence of allelic variation on apolipoprotein(a) folding in the endoplasmic reticulum. J. Biol. Chem. 272: 5048-5055.
169. Lobentanz, E-M., K. Krasznai, A. Gruber, C. Brunner, H-J. Möller, J. Sattler, H-G. Kraft, G. Utermann, and H. Dieplinger. 1998. Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells. Biochemistry. 37: 5417-5425.
170. Marcovina, S. M., J. J. Albers, D. R. Jacobs, Jr., L. L. Perkins, C. E. Lewis, B. V. Howard, and P. Savage. 1993. Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans: The CARDIA Study. Arterioscler. Thromb. 13: 1037-1045.
171. Ali, S., C. H. Bunker, C. E. Aston, F. A. Ukoli, and M. I. Kamboh. 1998. Apolipoprotein A kringle 4 polymorphism and serum lipoprotein (a) concentrations in African blacks. Hum. Biol. 70: 477-490.
172. Helmhold, M., J. Bigge, R. Muche, J. Mainoo, J. Thiery, D. Seidel, and V. W. Armstrong. 1991. Contribution of the apo[a] phenotype to plasma Lp[a] concentrations shows considerable ethnic variation. J. Lipid Res. 32: 1919-1928.
173. Geethanjali, F. S., K. Luthra, A. Lingenhel, A. S. Kanagasaba-Pathy, J. Jacob, L. M. Srivastava, S. Vasisht, H. G. Kraft, and G. Utermann. 2003. Analysis of the apo(a) size polymorphism in Asian Indian populations: Association with Lp(a) concentration and coronary heart disease. Atherosclerosis. 169: 121-130.
174. Marcovina, S. M., J. J. Albers, E. Wijsman, Z. H. Zhang, N. H. Chapman, and H. Kennedy. 1996. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J. Lipid Res. 37: 2569-2585.
175. Mooser, V., F. P. Mancini, S. Bopp, A. Pethö-Schramm, R. Guerra, E. Boerwinkle, H-J. Möller, and H. H. Hobbs. 1995. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum. Mol. Genet. 4: 173-181.
176. Kronenberg, F., E. Kuen, E. Ritz, R. Junker, P. König, G. Kraatz, K. Lhotta, J. F. E. Mann, G. A. Möller, U. Neyer, et al. 2000. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J. Am. Soc. Nephrol. 11: 105-115.
177. Holmer, S. R., C. Hengstenberg, H. G. Kraft, B. Mayer, M. Poll, S. Kurzinger, M. Fischer, H. Lowel, G. Klein, G. A. Riegger, et al. 2003. Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction. Circulation. 107: 696-701.
178. Chretien, J. P., J. Coresh, Y. Berthier-Schaad, W. H. Kao, N. E. Fink, M. J. Klag, S. M. Marcovina, F. Giaculli, and M. W. Smith. 2006. Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans. J. Med. Genet. 43: 917-923.
179. Ogorelkova, M., H. G. Kraft, C. Ehnholm, and G. Utermann. 2001. Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians. Hum. Mol. Genet. 10: 815-824.
180. Deo, R. C., J. G. Wilson, C. Xing, K. Lawson, W. H. Kao, D. Reich, A. Tandon, E. Akylbekova, N. Patterson, T. H. Mosley, Jr., et al. 2011. Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans. PLoS One. 6: e14581.
181. Trommsdorff, M., S. Köchl, A. Lingenhel, F. Kronenberg, R. Delport, H. Vermaak, L. Lemming, I. C. Klausen, O. Faergeman, G. Utermann, et al. 1995. A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J. Clin. Invest. 96: 150-157.
182. Amemiya, H., T. Arinami, S. Kikuchi, K. Yamakawa-Kobayashi, L. Li, H. Fujiwara, M. Hiroe, F. Marumo, and H. Hamaguchi. 1996. Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease. Atherosclerosis. 123: 181-191.
183. Suzuki, K., M. Kuriyama, T. Saito, and A. Ichinose. 1997. Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J. Clin. Invest. 99: 1361-1366.
184. Mancini, F. P., V. Mooser, R. Guerra, and H. H. Hobbs. 1995. Sequence microheterogeneity in apolipoprotein(a) gene repeats and the relationship to plasma Lp(a) levels. Hum. Mol. Genet. 4: 1535-1542.
185. Bopp, S., S. Kochl, F. Acquati, P. Magnaghi, A. Petho-Schramm, H. G. Kraft, G. Utermann, H. J. Muller, and R. Taramelli. 1995. Ten allelic apolipoprotein[a] 5′ flanking fragments exhibit comparable promoter activities in HepG2 cells. J. Lipid Res. 36: 1721-1728.
186. Ichinose, A. 1995. Characterization of the apolipoprotein(a) gene. Biochem. Biophys. Res. Commun. 209: 365-371.
187. Ichinose, A., and M. Kuriyama. 1995. Detection of polymorphisms in the 5′-flanking region of the gene for apolipoprotein(a). Biochem. Biophys. Res. Commun. 209: 372-378.
188. Zysow, B. R., G. E. Lindahl, D. P. Wade, B. L. Knight, and R. M. Lawn. 1995. C/T polymorphism in the 5′ untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler. Thromb. Vasc. Biol. 15: 58-64.
189. Kraft, H. G., M. Windegger, H. J. Menzel, and G. Utermann. 1998. Significant impact of the +93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in Caucasians: confounding effect of linkage disequilibrium. Hum. Mol. Genet. 7: 257-264.
190. Prins, J., F. R. Leus, B. N. Bouma, and H. J. van Rijn. 1999. The identification of polymorphisms in the coding region of the apolipoprotein (a) gene-Association with earlier identified polymorphic sites and influence on the lipoprotein (a) concentration. Thromb. Haemost. 82: 1709-1717.
191. Rainwater, D. L., C. M. Kammerer, J. L. VandeBerg, and J. E. Hixson. 1997. Characterization of the genetic elements controlling lipoprotein(a) concentrations in Mexican Americans. Evidence for at least three controlling elements linked to LPA, the locus encoding apolipoprotein(a). Atherosclerosis. 128: 223-233.
192. Wade, D. P., L. H. Puckey, B. L. Knight, F. Acquati, A. Mihalich, and R. Taramelli. 1997. Characterization of multiple enhancer regions upstream of the apolipoprotein(a) gene. J. Biol. Chem. 272: 30387-30399.
193. Puckey, L. H., and B. L. Knight. 2003. Sequence and functional changes in a putative enhancer region upstream of the apolipoprotein(a) gene. Atherosclerosis. 166: 119-127.
194. van der Hoek, Y. Y., M. E. Wittekoek, U. Beisiegel, J. J. P. Kastelein, and M. L. Koschinsky. 1993. The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum. Mol. Genet. 2: 361-366.
195. Kraft, H. G., C. Haibach, A. Lingenhel, C. Brunner, M. Trommsdorff, F. Kronenberg, H. J. Möller, and G. Utermann. 1995. Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein (a) size polymorphism. Hum. Genet. 95: 275-282.
196. Luke, M. M., J. P. Kane, D. M. Liu, C. M. Rowland, D. Shiffman, J. Cassano, J. J. Catanese, C. R. Pullinger, D. U. Leong, A. R. Arellano, et al. 2007. A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 27: 2030-2036.
197. Lanktree, M. B., S. S. Anand, S. Yusuf, and R. A. Hegele. 2010. Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Circ Cardiovasc Genet. 3: 39-46.
198. Lu, W., Y. C. Cheng, K. Chen, H. Wang, G. S. Gerhard, C. D. Still, X. Chu, R. Yang, A. Parihar, J. R. O'Connell, et al. 2015. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels. Hum. Mol. Genet. 24: 2390-2400.
199. Auton, A., L. D. Brooks, R. M. Durbin, E. P. Garrison, H. M. Kang, J. O. Korbel, J. L. Marchini, S. McCarthy, G. A. McVean, and G. R. Abecasis. 2015. A global reference for human genetic variation. Nature. 526: 68-74.
200. Noureen, A., F. Fresser, G. Utermann, and K. Schmidt. 2015. Sequence variation within the KIV-2 copy number polymorphism of the human LPA gene in African, Asian, and European populations. PLoS One. 10: e0121582.
201. Khalifa, M., A. Noureen, K. Ertelthalner, A. R. Bandegi, R. Delport, W. J. Firdaus, F. S. Geethanjali, K. Luthra, O. Makemaharn, R. W. Pang, et al. 2015. Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians. Atherosclerosis. 242: 521-528.
202. Kronenberg, F. 2014. Genetic determination of lipoprotein(a) and its association with cardiovascular disease. Convenient does not always mean better. J. Intern. Med. 276: 243-247.
203. Dahlen, G. H., J. R. Guyton, M. Attar, J. A. Farmer, J. A. Kautz, and A. M. Gotto, Jr. 1986. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 74: 758-765.
204. Kostner, G. M., P. Avogaro, G. Cazzolato, E. Marth, G. Bittolo-Bon, and G. B. Qunici. 1981. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis. 38: 51-61.
205. Orth-Gomér, K., M. A. Mittleman, K. Schenck-Gustafsson, S. P. Wamala, M. Eriksson, K. Belkic, R. Kirkeeide, B. Svane, and L. Rydén. 1997. Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation. 95: 329-334.
206. Rhoads, G. G., G. Dahlen, K. Berg, N. E. Morton, and A. L. Dannenberg. 1986. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 256: 2540-2544.
207. Ridker, P. M., C. H. Hennekens, and M. J. Stampfer. 1993. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA. 270: 2195-2199.
208. Rifai, N., J. Ma, F. M. Sacks, P. M. Ridker, W. J. Hernandez, M. J. Stampfer, and S. M. Marcovina. 2004. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study. Clin. Chem. 50: 1364-1371.
209. Erqou, S., S. Kaptoge, P. L. Perry, A. E. Di, A. Thompson, I. R. White, S. M. Marcovina, R. Collins, S. G. Thompson, and J. Danesh. 2009. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 302: 412-423.
210. Sandholzer, C., E. Boerwinkle, N. Saha, M. C. Tong, and G. Utermann. 1992. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: Evidence for the role of the apo(a) gene in coronary heart disease. J. Clin. Invest. 89: 1040-1046.
211. Kronenberg, F., U. Neyer, K. Lhotta, E. Trenkwalder, M. Auinger, A. Pribasnig, T. Meisl, P. König, and H. Dieplinger. 1999. The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: A prospective follow-up. J. Am. Soc. Nephrol. 10: 1027-1036.
212. Laschkolnig, A., B. Kollerits, C. Lamina, C. Meisinger, B. Rantner, M. Stadler, A. Peters, W. Koenig, A. Stöckl, D. Dähnhardt, et al. 2014. Lipoprotein(a) concentrations, apolipoprotein(a) phenotypes and peripheral arterial disease in three independent cohorts. Cardiovasc. Res. 103: 28-36.
213. Kronenberg, F. 2016. Human genetics and the causal role of lipoprotein(a) for various diseases. Cardiovasc. Drugs Ther. 30: 87-100.
214. Zacho, J., A. Tybjaerg-Hansen, J. S. Jensen, P. Grande, H. Sillesen, and B. G. Nordestgaard. 2008. Genetically elevated C-reactive protein and ischemic vascular disease. N. Engl. J. Med. 359: 1897-1908.
215. Wensley, F., P. Gao, S. Burgess, S. Kaptoge, A. E. Di, T. Shah, J. C. Engert, R. Clarke, G. Davey-Smith, B. G. Nordestgaard, et al. 2011. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 342: d548.
216. Katan, M. B. 1986. Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet. 1: 507-508.
217. Li, Y., M. M. Luke, D. Shiffman, and J. J. Devlin. 2011. Genetic variants in the apolipoprotein(a) gene and coronary heart disease. Circ Cardiovasc Genet. 4: 565-573.
218. Trégouët, D. A., I. R. Konig, J. Erdmann, A. Munteanu, P. S. Braund, A. S. Hall, A. Grosshennig, P. Linsel-Nitschke, C. Perret, M. DeSuremain, et al. 2009. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat. Genet. 41: 283-285.
219. Shiffman, D., J. Z. Louie, C. M. Rowland, M. J. Malloy, J. P. Kane, and J. J. Devlin. 2010. Single variants can explain the association between coronary heart disease and haplotypes in the apolipoprotein(a) locus. Atherosclerosis. 212: 193-196.
220. Koch, W., J. C. Mueller, M. Schrempf, H. Wolferstetter, J. Kirchhofer, A. Schomig, and A. Kastrati. 2013. Two rare variants explain associa tion with acute myocardial infarction in an extended genomic region including the apolipoprotein(A) gene. Ann. Hum. Genet. 77: 47-55.
221. Kyriakou, T., U. Seedorf, A. Goel, J. C. Hopewell, R. Clarke, H. Watkins, and M. Farrall. 2014. A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk. Arterioscler. Thromb. Vasc. Biol. 34: 2095-2099.
222. Paultre, F., T. A. Pearson, H. F. Weil, C. H. Tuck, M. Myerson, J. Rubin, C. K. Francis, H. F. Marx, E. F. Philbin, R. G. Reed, et al. 2000. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and White men. Arterioscler. Thromb. Vasc. Biol. 20: 2619-2624.
223. Moliterno, D. J., E. V. Jokinen, A. R. Miserez, R. A. Lange, J. E. Willard, E. Boerwinkle, L. D. Hillis, and H. H. Hobbs. 1995. No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler. Thromb. Vasc. Biol. 15: 850-855.
224. Guerra, R., Z. Yu, S. Marcovina, R. Peshock, J. C. Cohen, and H. H. Hobbs. 2005. Lipoprotein(a) and apolipoprotein(a) isoforms. No association with coronary artery calcification in The Dallas Heart Study. Circulation. 111: 1471-1479.
225. Mersha, T. B., and T. Abebe. 2015. Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities. Hum. Genomics. 9: 1.
226. Reed, F. A., and S. A. Tishkoff. 2006. African human diversity, origins and migrations. Curr. Opin. Genet. Dev. 16: 597-605.
227. Shiffman, D., K. Slawsky, L. Fusfeld, J. J. Devlin, and T. F. Goss. 2012. Cost-effectiveness model of use of genetic testing as an aid in assessing the likely benefit of aspirin therapy for primary prevention of cardiovascular disease. Clin. Ther. 34: 1387-1394.
228. Takeuchi, F., M. Yokota, K. Yamamoto, E. Nakashima, T. Katsuya, H. Asano, M. Isono, T. Nabika, T. Sugiyama, A. Fujioka, et al. 2012. Genome-wide association study of coronary artery disease in the Japanese. Eur. J. Hum. Genet. 20: 333-340.
229. Rowland, C. M., C. R. Pullinger, M. M. Luke, D. Shiffman, L. Green, I. Movsesyan, J. J. Devlin, M. J. Malloy, J. P. Kane, and A. Undas. 2014. Lipoprotein (a), LPA Ile4399Met, and fibrin clot properties. Thromb. Res. 133: 863-867.
230. Li, Z. G., G. Li, Y. L. Zhou, Z. J. Chen, J. Q. Yang, Y. Zhang, S. Sun, and S. L. Zhong. 2013. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention. Lipids Health Dis. 12: 127.
231. van der Hoek, Y. Y., A. Lingenhel, H. G. Kraft, J. C. Defesche, J. J. P. Kastelein, and G. Utermann. 1997. Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familiar defective ApoB. J. Clin. Invest. 99: 2269-2273.
232. Sandholzer, C., G. Feussner, J. Brunzell, and G. Utermann. 1992. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency with type III hyperlipoproteinemia: no evidence for a triglyceride-rich precursor of lipoprotein(a). J. Clin. Invest. 90: 1958-1965.
233. Menzel, H-J., H. Dieplinger, C. Lackner, F. Hoppichler, J. K. Lloyd, D. R. Muller, C. Labeur, P. J. Talmud, and G. Utermann. 1990. Abetalipoproteinemia with an apoB-100-lipoprotein(a) glycoprotein complex in plasma: indication for an assembly defect. J. Biol. Chem. 265: 981-986.
234. Li, J., L. A. Lange, J. Sabourin, Q. Duan, W. Valdar, M. S. Willis, Y. Li, J. G. Wilson, and E. M. Lange. 2015. Genome-And exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study. J. Hum. Genet. 60: 755-761.
235. Thanassoulis, G., C. Y. Campbell, D. S. Owens, J. G. Smith, A. V. Smith, G. M. Peloso, K. F. Kerr, S. Pechlivanis, M. J. Budoff, T. B. Harris, et al. 2013. Genetic associations with valvular calcification and aortic stenosis. N. Engl. J. Med. 368: 503-512.
236. Kamstrup, P. R., A. Tybjaerg-Hansen, and B. G. Nordestgaard. 2014. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J. Am. Coll. Cardiol. 63: 470-477.
237. Arsenault, B. J., S. M. Boekholdt, M. P. Dube, E. Rheaume, N. J. Wareham, K. T. Khaw, M. S. Sandhu, and J. C. Tardif. 2014. Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: A prospective mendelian randomization study and replication in a case-control cohort. Circ Cardiovasc Genet. 7: 304-310.
238. Capoulade, R., K. L. Chan, C. Yeang, P. Mathieu, Y. Bosse, J. G. Dumesnil, J. W. Tam, K. K. Teo, A. Mahmut, X. Yang, et al. 2015. Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis. J. Am. Coll. Cardiol. 66: 1236-1246.
239. Kamstrup, P. R., and B. G. Nordestgaard. 2016. Elevated lipoprotein(a) levels, LPA risk genotypes, and increased risk of heart failure in the general population. JACC Heart Fail. 4: 78-87.
240. Young, G., M. Albisetti, M. Bonduel, L. Brandao, A. Chan, F. Friedrichs, N. A. Goldenberg, E. Grabowski, C. Heller, J. Journeycake, et al. 2008. Impact of inherited thrombophilia on venous thromboembolism in children: A systematic review and meta-Analysis of observational studies. Circulation. 118: 1373-1382.
241. Lamina, C., and F. Kronenberg. 2013. The mysterious lipoprotein(a) is still good for a surprise. Lancet Diabetes Endocrinol. 1: 170-172.